ACL Related Rumors
-
Nestle Has An Extra $28 Billion, And Now Could Go After GIS or MJN - CNBC
-
Novartis for Alcon (ACL)? Novartis Says "No" But Market Says "Yes"
-
Despite Novartis Denial, UBS Makes A Strong Case That They Should Buy Alcon (ACL)
-
Novartis (NVS) has no plans to buy out Alcon (ACL) minority shares - Bloomberg
-
Alcon (ACL) Jumps On Takeover Chatter
-
Wachovia Upgrades Alcon (ACL) to Outperform, Strong Chance Company Acquired by Novartis (NVS)
Back to ACL Stock Lookup
